Sunday, September 30, 2018

Mankind Pharma eyes $1 billion topline by FY21

Mankind Pharma eyes $1 billion topline by FY21 The company is also looking at increasing its exports substantially to $100-150 million in the next three years from the present $10 million.

from Moneycontrol Business News https://ift.tt/2Qla994

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...